CompletedNCT00169065
Clozapine compared with olanzapine for treatment-resistant schizophrenia
About this title
Read the official source — NCT00169065Medication studyAges 20–60United States
Understand this study
Who was this study for?
Listed age limits: 20 years to 60 years.
- Listed locations
- Jamaica PlainSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateAugust 1998
- Recruitment status
- Completed
- Enrollment listed in the registry
- 38
- Sponsor
- Harvard Medical School (HMS and HSDM)
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 20 Years to 60 Years
- Official registry ID
- NCT00169065
- Official title
Show the full official title
Clozapine vs. Olanzapine: An Effectiveness Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Jamaica Plain
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Harvard Medical School (HMS and HSDM).
Did this study involve medication?
Yes. The study involved medication, including Clozapine and Olanzapine.
Who was this study for?
Listed age limits: 20 years to 60 years.
